Cargando…
Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?
Glioblastoma (GBM), the most common primary malignant brain tumor, is associated with a dismal prognosis. Standard therapies including maximal surgical resection, radiotherapy, and temozolomide chemotherapy remain poorly efficient. Improving GBM treatment modalities is, therefore, a paramount challe...
Autores principales: | Echavidre, William, Picco, Vincent, Faraggi, Marc, Montemagno, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144720/ https://www.ncbi.nlm.nih.gov/pubmed/35631639 http://dx.doi.org/10.3390/pharmaceutics14051053 |
Ejemplares similares
-
Recent Pre-Clinical Advancements in Nuclear Medicine: Pioneering the Path to a Limitless Future
por: Echavidre, William, et al.
Publicado: (2023) -
Therapeutic Radiopharmaceuticals Targeting Integrin
αvβ6
por: Färber, Stefanie Felicitas, et al.
Publicado: (2018) -
Therapeutic Targeting of Integrin αvβ6 in Breast Cancer
por: Moore, Kate M., et al.
Publicado: (2014) -
Integrins α(v)β(3) and α(v)β(5) as prognostic, diagnostic, and therapeutic targets in gastric cancer
por: Böger, Christine, et al.
Publicado: (2014) -
The αvβ3 integrin as a therapeutic target for inhibition of bone resorption
por: Dixon, SJ, et al.
Publicado: (2004)